Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Non-Invasive Prenatal Testing and Carrier Screening are the Key Segments Triggering Growth Across the Market
save 15 %
* Required Fields
Pay by invoice
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseases. Women's healthcare, however, especially in less-developed settings, remains mostly confined to reproductive issues, particularly maternal health. Attention to other significant women’s health issues, such as oncology, reproductive health, and urology, is growing rapidly. Overall, advancements in women’s health diagnostic products are intense, and diagnostic technologies have been subjected to rapid change. Two key market drivers are the rising occurrence of lifestyle disorders among women and growing awareness of women-specific health issues. The other drivers include the rise in the number of private diagnostic labs (mostly in emerging nations), health initiatives/drives taken by governments and other health organizations, and new approvals for easy-to-use rapid tests. Nevertheless, the lack of skillful lab professionals and high set-up costs of diagnostic devices/systems are some key growth restraints in the women’s health diagnostics market.Currently, women’s health diagnostic products are being targeted at markets outside of traditional hospitals or clinical laboratories. The demand for home healthcare services in women’s health is facing a steady increase; however, at the same time, there is pressure to lower costs and maintain the high quality of the care delivered at home. Continuous improvements in technology are bringing about a number of new diagnostic tests that consolidate high levels of accuracy with rapid, easy-to-use product designs. A gradual rise in infertility rates because of stressful lifestyles is triggering growth in the global pregnancy and fertility testing market. Additionally, point-of-care testing (POCT) devices that monitor ovulation and detect pregnancy are easy to use and cost effective, which are key propelling factors for the POCT market. Prenatal genetic tests that are predominantly used to test disorders, such as aneuploidies in chromosomes 21, 18, and 13 and carrier screens, are gaining momentum because of enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to become pregnant at an advanced age. This strategic research service provides key growth drivers as well as the current competitive landscape in the women's reproductive health diagnostics market. In addition, this service covers the market size and growth rate forecast for 2016 and 2021. The scope of the study includes the women's reproductive health diagnostics market, which has been categorized into POC/molecular tests, lab instrumentation, and surgical instruments.Key Questions This Study Will Answer:What are the key market opportunities that make this an attractive market, with a significant future revenue potential for companies?What is the growth potential for women’s reproductive health diagnostics solutions as well as the sub-segments across different geographies?What are the key growth drivers that companies should focus on to remain relevant and competitive in this market?Which are the top game-changing companies in women’s reproductive health diagnostics, and what are their leading product portfolios?
Chinese In-vitro Diagnostics Market Insight, Forecast to 2023
US Cardiac Troponin Diagnostics Market, Forecast to 2021
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021
Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021
Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017
Strategic Insight into the Global Women’s Oncology Diagnostics Market, 2017
Strategic Insight into the Global Women’s Cardiology Diagnostics Market, 2017
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies
Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021
fleet management market
cyber security market
wound care market
biometric authentication market
heavy commercial vehicles market
flexible electronics market
augmented reality market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.